Sol-Del Medical
Medical PVA Soluble Delivery Platform
Company Overview
Snapshot
Founded in September 2017, Sol-Del Medical operated with 1–10 employees. The company secured funding across two rounds from two investors. In July 2022, OurCrowd participated in a Seed funding round.
Business overview
Sol-Del Medical developed an innovative medical-grade Polyvinyl Alcohol (PVA) soluble delivery system. This technology is designed for the generic insertion of FDA-cleared medicines, including topical treatments, OTC creams, ointments, or oils. The company's advanced topical dressing features a multi-cell soluble Medical PVA film that enables the controlled release of active agents to the skin upon contact with aqueous fluids like perspiration or external water-based solutions. Sol-Del Medical operates within the Health Tech & Life Sciences sector, focusing on drug delivery and pharmaceutical applications.
Log in to access full profile ›Company Intelligence Q&A
- What is Sol-Del Medical's primary focus?
- Sol-Del Medical specializes in the development and production of a new innovative Medical PVA soluble delivery system, designed for the controlled release of active agents for topical treatments.
- When was Sol-Del Medical founded?
- Sol-Del Medical was founded in September 2017.
- What is the status of Sol-Del Medical?
- Sol-Del Medical is currently non-active, having ceased operations in January 2025.